NYBC Ventures

NYBC Ventures is the corporate venture capital arm of New York Blood Center Enterprises, based in New York and launched with a $50M commitment. It backs early to mid-stage blood, cellular therapy and related life sciences innovations, including hematology, transfusion medicine, cell therapy, infectious disease, oncology and enabling technologies. The firm has invested from seed through later-stage venture rounds and focuses primarily on the United States with observed activity in the United Kingdom.